Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

A young woman recovered well from rare simultaneous Hepatitis B and autoimmune hepatitis after treatment.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

The woman was diagnosed with systemic lupus erythematosus (SLE) after initial misdiagnosis and improved with proper treatment.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

People with alopecia areata are more likely to have thyroid autoimmunity, but not thyroid disease.

A complex X chromosome rearrangement can increase the risk of multiple autoimmune diseases.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

Skin and mucous symptoms are key for diagnosing autoimmune connective tissue diseases.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Dystonia may be part of PAS-4 and linked to immune issues.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

A3 antibody helps identify key cells in rat hair follicle development.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

Autoimmune Polyendocrine Syndromes involve specific combinations of endocrine and non-endocrine autoimmune diseases.

Certain genes are linked to the risk of developing Alopecia Areata.

Membership in a self-help organization is linked to being better informed and having a higher education, but it doesn't clearly affect disease outcomes.